BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 28288659)

  • 1. A clinical model for identifying the short-term risk of breast cancer.
    Eriksson M; Czene K; Pawitan Y; Leifland K; Darabi H; Hall P
    Breast Cancer Res; 2017 Mar; 19(1):29. PubMed ID: 28288659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heritability of Mammographic Breast Density, Density Change, Microcalcifications, and Masses.
    Holowko N; Eriksson M; Kuja-Halkola R; Azam S; He W; Hall P; Czene K
    Cancer Res; 2020 Apr; 80(7):1590-1600. PubMed ID: 32241951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection.
    Chiarelli AM; Prummel MV; Muradali D; Shumak RS; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ
    Breast Cancer Res Treat; 2015 Nov; 154(2):377-87. PubMed ID: 26518019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening.
    Eriksson M; Czene K; Strand F; Zackrisson S; Lindholm P; Lång K; Förnvik D; Sartor H; Mavaddat N; Easton D; Hall P
    Radiology; 2020 Nov; 297(2):327-333. PubMed ID: 32897160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
    Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and tumor characteristics of interval cancers by mammographic density.
    Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
    J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [THE EFFECTS OF HORMONAL REPLACEMENT THERAPY (HRT) ON MAMMOGRAPHIC BREAST DENSITY AND ABNORMAL MAMMOGRAMS PROMPTING FURTHER INVESTIGATION].
    Barda L; Nevler A; Rosin D; Shabtai EL; Gutman M; Shabtai M
    Harefuah; 2019 Apr; 158(4):239-243. PubMed ID: 31032556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-control study of increased mammographic breast density response to hormone replacement therapy.
    Vachon CM; Sellers TA; Vierkant RA; Wu FF; Brandt KR
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1382-8. PubMed ID: 12433715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion of Endogenous Plasma Dehydroepiandrosterone Sulfate and Mammographic Density in Risk Prediction Models for Breast Cancer.
    Gabrielson M; Ubhayasekera KA; Acharya SR; Franko MA; Eriksson M; Bergquist J; Czene K; Hall P
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):574-581. PubMed ID: 31948996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of five methods of measuring mammographic density: a case-control study.
    Astley SM; Harkness EF; Sergeant JC; Warwick J; Stavrinos P; Warren R; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Brentnall AR; Cuzick J; Howell T; Evans DG
    Breast Cancer Res; 2018 Feb; 20(1):10. PubMed ID: 29402289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study.
    Azam S; Lange T; Huynh S; Aro AR; von Euler-Chelpin M; Vejborg I; Tjønneland A; Lynge E; Andersen ZJ
    Cancer Causes Control; 2018 Jun; 29(6):495-505. PubMed ID: 29671181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
    Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
    Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
    Abdolell M; Payne JI; Caines J; Tsuruda K; Barnes PJ; Talbot PJ; Tong O; Brown P; Rivers-Bowerman M; Iles S
    Eur Radiol; 2020 Oct; 30(10):5417-5426. PubMed ID: 32358648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary investigation of mammographic density among women in Riyadh: association with breast cancer risk factors and implications for screening practices.
    Albeshan SM; Hossain SZ; Mackey MG; Peat JK; Al Tahan FM; Brennan PC
    Clin Imaging; 2019; 54():138-147. PubMed ID: 30639525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic density and structural features can individually and jointly contribute to breast cancer risk assessment in mammography screening: a case-control study.
    Winkel RR; von Euler-Chelpin M; Nielsen M; Petersen K; Lillholm M; Nielsen MB; Lynge E; Uldall WY; Vejborg I
    BMC Cancer; 2016 Jul; 16():414. PubMed ID: 27387546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography.
    Carney PA; Miglioretti DL; Yankaskas BC; Kerlikowske K; Rosenberg R; Rutter CM; Geller BM; Abraham LA; Taplin SH; Dignan M; Cutter G; Ballard-Barbash R
    Ann Intern Med; 2003 Feb; 138(3):168-75. PubMed ID: 12558355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammographic features associated with interval breast cancers in screening programs.
    Boyd NF; Huszti E; Melnichouk O; Martin LJ; Hislop G; Chiarelli A; Yaffe MJ; Minkin S
    Breast Cancer Res; 2014 Aug; 16(4):417. PubMed ID: 25346388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Cancer Risk and Mammographic Density Assessed with Semiautomated and Fully Automated Methods and BI-RADS.
    Jeffers AM; Sieh W; Lipson JA; Rothstein JH; McGuire V; Whittemore AS; Rubin DL
    Radiology; 2017 Feb; 282(2):348-355. PubMed ID: 27598536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status.
    Malkov S; Shepherd JA; Scott CG; Tamimi RM; Ma L; Bertrand KA; Couch F; Jensen MR; Mahmoudzadeh AP; Fan B; Norman A; Brandt KR; Pankratz VS; Vachon CM; Kerlikowske K
    Breast Cancer Res; 2016 Dec; 18(1):122. PubMed ID: 27923387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.